Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NBI-3001 in Recurrent Glioblastoma Multiforme
NCT00014677Phase 2Completed
- Sponsor
- Neurocrine Biosciences
- Start
- Mar 2001
- Primary completion
- Sep 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carisbamate in glioblastoma multiforme (GBM), sponsored by Neurocrine Biosciences. Started Mar 2001; status: completed.
02
Drugs
carisbamate
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00014677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00014677.